PAUL THOMAS
CIK 1166776 · President and CEO · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.35M
Companies
11
Total Filings
75
Lifetime Open-Market Net
-$15.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AXGN | Director | 32,395 | $41.15 | $1.33M | -$633.7K | 12 | 2026-06-26 |
| TELA | Director | 23,600 | $0.67 | $15.8K | $0 | 1 | 2026-06-11 |
| ABIOMED INC (ABMD) Delisted | Director | 6,357 | $381.02 | $2.42M | -$3.42M | 13 | 2022-11-03 |
| SURGALIGN HOLDINGS, INC. (SRGA) Delisted | Director | 28,610 | $0.18 | $5.2K | $0 | 3 | 2022-08-17 |
| RTI SURGICAL, INC. (RTIX) Delisted | Director | 0 | — | — | $0 | 5 | 2019-03-11 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Director | 0 | — | — | $0 | 6 | 2016-11-30 |
| Roka BioScience, Inc. (ROKA) Delisted | President and CEO | 85,494 | — | — | $0 | 4 | 2016-11-10 |
| ABIOMED INC (APOL) Delisted | Director | 22,932 | — | — | -$2.60M | 11 | 2016-08-11 |
| KINETIC CONCEPTS INC (KCI) Delisted | President, LifeCell Corp. | 0 | — | — | $0 | 1 | 2008-08-27 |
| LIFECELL CORP (VITA) Delisted | Chairman, President and CEO | 0 | — | — | -$8.66M | 10 | 2008-06-04 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 38,931 | — | — | $0 | 1 | 2007-03-05 |
Recent Filings · Page 2 of 8
75 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-05 | AXGN | Exer (M) | +6,459 | $0 | EDGAR |
| 2022-12-27 | — | Disp (D) | −6,357 | $0 | |
| 2022-11-03 | ABIOMED INC (ABMD) Delisted | Sell (S) | −1,000 | -$379.4K | EDGAR |
| 2022-08-17 | SURGALIGN HOLDINGS, INC. (SRGA) Delisted | Grant (A) | +22,857 | $0 | EDGAR |
| 2022-08-12 | ABIOMED INC (ABMD) Delisted | Mixed | +449 | -$68.1K | EDGAR |
| 2022-06-03 | AXGN | Mixed | +3,036 | $0 | EDGAR |
| 2021-08-19 | ABIOMED INC (ABMD) Delisted | Sell (S) | −663 | -$219.3K | EDGAR |
| 2021-08-13 | ABIOMED INC (ABMD) Delisted | Mixed | +380 | -$78.4K | EDGAR |
| 2021-07-02 | SURGALIGN HOLDINGS, INC. (SRGA) Delisted | Grant (A) | +72,254 | $0 | EDGAR |
| 2021-06-03 | AXGN | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.